On August 14, 2026, Chelsea FC Women announced it will launch a fertility fund giving every player in its women's team access to fertility assessments, treatments, counselling and workshops, as part of a new partnership with London clinic Fertility Plus — named the club's first Official Fertility Partner. Femtech World and Femtech Insider both reported the deal, which the club describes as first-of-its-kind.

Why It Matters

Elite women's football runs on a career window that overlaps almost perfectly with peak fertility — roughly ages 20 to 33 — and the sport has historically offered no institutional answer beyond "retire or wait." A club-funded fertility benefit converts a private, career-limiting calculation into an employment benefit, which is precisely the framing that has driven fertility coverage into corporate benefits packages over the past decade. The commercial layer is what makes this a sextech-industry story rather than a sports one. Fertility Plus becomes an official club partner — the same sponsorship real estate normally sold to banks and betting firms — which means reproductive health has cleared the brand-safety bar in top-flight European football. That's the same threshold Sequel crossed in the WNBA, where a spiral tampon startup this month added a Fever star as co-owner. Two elite women's leagues, two weeks, two reproductive-health brands buying the front of the shirt. For femtech operators, the takeaway is a viable channel that sidesteps the ad-platform restrictions strangling the category: sponsorship and partnership deals in women's sports deliver reach, credibility and a use-case-aligned audience that Meta and TikTok will not sell you at any price.

Support delivered through Fertility Plus will span assessments and treatments as well as counselling and workshops, with the fund available to every player and tailored to individual needs. The partnership also carries an education mandate beyond the squad: the club and clinic plan to publish evidence-based reproductive health content, resources comparing fertility myths against medical evidence, and insights from Chelsea FC Women ambassadors. Chelsea cited prior research on fertility knowledge finding that 41% of respondents actively trying to conceive did not know when their fertile window was.

"At Chelsea FC Women we are never done pushing for progress for our players and our community," said Giulia Mazzia, commercial director for Chelsea FC Women. "This first-of-its-kind partnership with Fertility Plus will open up the conversation about fertility, help to raise awareness for our incredible fanbase and beyond, and give practical support to our players off the field as well as on it."

Fertility Plus co-founders Dr. Amit Shah and Dr. Anil Gudi framed the underlying problem bluntly: "Elite sport asks a lot of women during the very years when fertility matters most, yet it's a conversation the game has rarely had. Partnering with Chelsea FC Women allows us to help change that by giving players, staff and supporters access to trusted fertility expertise and compassionate, consultant-led care."

Sources

Update — 2026-08-19

Initial entry — story first created.